Cargando…
Impact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: Comparison between an everolimus- and a standard tacrolimus-based regimen
BACKGROUND: The gut microbiome is the full set of microbes living in the gastrointestinal tract and is emerging as an important dynamic/fluid system that, if altered by environmental, dietetic or pharmacological factors, could considerably influence drug response. However, the immunosuppressive drug...
Autores principales: | Zaza, Gianluigi, Dalla Gassa, Alessandra, Felis, Giovanna, Granata, Simona, Torriani, Sandra, Lupo, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443527/ https://www.ncbi.nlm.nih.gov/pubmed/28542523 http://dx.doi.org/10.1371/journal.pone.0178228 |
Ejemplares similares
-
Personalization of the Immunosuppressive Treatment in Renal Transplant Recipients: The Great Challenge in “Omics” Medicine
por: Zaza, Gianluigi, et al.
Publicado: (2015) -
Sirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular Effects
por: Granata, Simona, et al.
Publicado: (2016) -
Mitochondria: a new therapeutic target in chronic kidney disease
por: Granata, Simona, et al.
Publicado: (2015) -
Transcriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney Disease
por: Granata, Simona, et al.
Publicado: (2016) -
Efficacy and Safety of Low-Dose Everolimus as Maintenance Immunosuppression in Cardiac Transplant Recipients
por: Fuchs, Uwe, et al.
Publicado: (2012)